Saudi startup funding is getting bigger — but also more concentrated

Category: Funding & VC

By TechScoop Desk

Published: 2026-09-24T07:48:00.000Z

Two rounds — Tabby's and barq's — account for well over half of September's disclosed Saudi startup capital. The totals are growing, but the money is landing in fewer, larger checks.

Two rounds, most of the money It is rare for a single statistic to summarize an entire month's funding activity as cleanly as this one does, which is exactly why it deserves to open this piece rather than sit buried inside a longer list of individual rounds. Add up September's disclosed Saudi startup rounds and a striking pattern appears: two deals — Tabby's $233 million Series F and barq's $329.5 million Series A — together account for more than $560 million, well over half of everything disclosed this month across every sector combined. That is the clearest evidence yet that Saudi startup funding, while growing in absolute terms, is concentrating into fewer and much larger checks rather than spreading more evenly across the market. Mega-rounds versus everything else Beneath those two rounds sits a wide gap. The next tier down — Tarabut's $50 million, Rize's $50 million facility, FlyAkeed's $25.15 million, Nayla's $18 million and Enhance's $18.2 million — are all substantial rounds by regional standards, yet each is a fraction of either mega-round's size. Below that sits a long list of seed and pre-seed rounds in the low single-digit millions: Abwab.ai's $4 million, RIME's more than $2 million, Gaia's $1.5 million, Remedium's $1.5 million, Rwaj's $1.2 million and Fitting's $1.1 million. The distribution is heavily skewed: a handful of outsized rounds at the top, a long tail of small checks at the bottom, and comparatively little in between. Sector concentration follows the same pattern The concentration is not just about round size — it is also about sector. Fintech alone accounts for the two largest rounds of the month plus several of the mid-sized ones (Tarabut, Rize, Nayla), meaning a single sector is responsible for the majority of disclosed capital. AI, by contrast, produced a run of small deals with the smallest average size. That combination — one sector taking most of the dollars while another supplies much of the early-stage deal flow — is itself a form of concentration risk if it persists: a downturn in fintech appetite would remove most of the capital, while a slowdown in AI seed activity would remove most of the deal flow without moving the totals much. The middle of the market is where concentration actually hurts Concentration is easiest to see at the extremes, but it is the middle of the distribution that actually determines how healthy the pipeline looks a few years out. The starkest evidence of concentration is not the gap between barq's round and the smallest seed deals — that gap exists in every startup market in the world. It is the comparatively thin middle: rounds in the $20 million to $100 million range, which is exactly where a company that has outgrown seed and Series A funding but has not yet reached mega-round status would normally raise, are thin on September's list. Tarabut's $50 million, Rize's $50 million facility and FlyAkeed's $25.15 million are the only examples, and even those sit well below the $200 million-plus tier at the top. A thin middle tier is the part of this distribution most worth watching in future months, since it is where the next generation of mega-round companies would need to pass through on their way up. Debt shows up at the top of the market Concentration also shows up in structure. Several of the larger rounds are not pure equity: Rize's facility from Jadwa Investment and the $200 million Lendo-Quantic SME financing programme both involve debt-like or credit-facility structures rather than straight equity dilution, while Enhance's $18.2 million round explicitly combines equity and venture debt. That mix tends to appear disproportionately in the largest deals, where balance-sheet capital is often more useful than additional equity. TechScoop looks at this in more depth in why debt is becoming a bigger part of Middle East startup funding . The case that concentration is a healthy sign, not a warning Before treating concentration as a problem to be solved, it is worth taking the opposing argument seriously on its own terms. It would be too simple to treat concentration purely as a risk. In most maturing venture markets, a small number of category-leading companies eventually pull away from the rest of the field and start absorbing a disproportionate share of available capital — that is close to the definition of a market developing genuine winners rather than a flat field of similarly sized early-stage bets. barq and Tabby raising rounds this large is only possible because investors believe both companies have already built defensible, large-scale businesses; that belief does not appear out of nowhere; it is typically earned through years of user growth, transaction volume and repeat investor engagement. Seen this way, concentration is partly just what it looks like when a young market's earliest bets start paying off. The risk that comes with it The more legitimate concern is what concentration does to everything below the top of the market. If mega-roun